Macular Degeneration Trial, Recruiting NCT07577219 Sponsor: New England College of Optometry Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT07577219
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have blind spots in the centre of their vision in both eyes, confirmed by a specific vision field test
  • People whose vision in at least one eye falls within a certain range of impairment (not fully sighted but not completely blind — roughly able to read large print but not standard print)
  • People whose central vision loss has been stable for at least the past 6 months, with no significant changes in that time
  • People aged 14 years or older who have been diagnosed with a disease affecting the macula (the central part of the eye)
  • People with normal cognitive (thinking and memory) function, as measured by a standard assessment score
  • People who are able to give their agreement to take part and attend all required study visits
  • People without significant hearing loss
  • People who are fluent in English

Who may not be able to join:

  • People whose eye condition is currently unstable, for example those currently receiving ongoing treatments or eye injections
  • People whose side (peripheral) vision covers less than 40 degrees in total
  • People who have conditions that affect eye movement control for reasons unrelated to their central vision loss

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 6175875626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
New England College of Optometry
Registry
ClinicalTrials.gov
Start date
31 January 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Saccadic Accuracy (Landing Error)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov